| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $38.5M | +0.7% |
| Cost of Revenue | $26.0M | +3.9% |
| Gross Profit | $12.5M | -5.3% |
| R&D Expense | $615K | +86.5% |
| SG&A Expense | $3.6M | +27.7% |
| Operating Income | $4.6M | -16.6% |
| Pre-tax Income | $3.3M | -34.0% |
| Income Tax | $900K | +5.7% |
| Net Income | $787K | -74.1% |
| EPS (Basic) | $0.06 | -75.0% |
| EPS (Diluted) | $0.06 | -75.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $12.6M | +7.9% |
| Inventory | $10.5M | -3.2% |
| Current Assets | $32.9M | -4.8% |
| Total Assets | $61.8M | +3.1% |
| Current Liabilities | $10.8M | -9.3% |
| Long-term Debt | $4.4M | -49.3% |
| Total Liabilities | $19.0M | +2.1% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.8M | -32.1% |
| Capital Expenditures | $4.4M | -11.9% |
| Investing Cash Flow | $891K | +136.3% |
| Financing Cash Flow | -$5.9M | -506.9% |
| Free Cash Flow | -$592K | -198.0% |
| $38.9M |
| +2.3% |